Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MDM2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
MDM2 is a gene implicated in neurodegeneration research. Key relationships include: activates, therapeutic target, regulates. Associated with Aging, Als, Alzheimer. Connected to 373 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | MDM2 |
| Full Name | MDM2 Proto-Oncogene, E3 Ubiquitin Protein Ligase |
| Chromosome | 12q15 |
| Protein Type | Ligase |
| Function | MDM2 is a RING-finger E3 ubiquitin ligase with multiple functions: |
| Primary Expression | neurons and glia - Higher expression in cortex and hippocampus - Regulated by neuronal activity |
| Molecular Weight | 55 kDa |
| Amino Acids | 491 aa |
| Pathways | NF-κB |
| UniProt ID | Q00978 |
| NCBI Gene ID | 4193 |
| Ensembl ID | ENSG00000135679 |
| OMIM | 164785 |
| GeneCards | MDM2 |
| Human Protein Atlas | MDM2 |
| Associated Diseases | aging, Als, Alzheimer |
| Known Drugs/Compounds | Pmiγ, PMIγ |
| Interactions | AGING, AKT, AMBRA1, AMPK, AND, APOPTOSIS |
| KG Connections | 530 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
MDM2["MDM2"]
MDM2 -->|"inhibits"| Tumor["Tumor"]
MDM2 -->|"inhibits"| Ms["Ms"]
MDM2 -->|"target for"| Cancer["Cancer"]
MDM2 -->|"target for"| Fibrosis["Fibrosis"]
MDM2 -->|"target for"| Als["Als"]
MDM2 -->|"regulates"| Glioblastoma["Glioblastoma"]
BCL2["BCL2"] -->|"inhibits"| MDM2
BCL2_FAMILY["BCL2 FAMILY"] -->|"inhibits"| MDM2
AKT["AKT"] -->|"target for"| MDM2
CASP3["CASP3"] -->|"target for"| MDM2
PI3K["PI3K"] -->|"target for"| MDM2
MAPK3["MAPK3"] -->|"target for"| MDM2
JUN["JUN"] -->|"target for"| MDM2
GENES["GENES"] -->|"target for"| MDM2| Target | Relation | Type | Str |
|---|---|---|---|
| Tumor | therapeutic_target | disease | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| Als | activates | disease | 1.00 |
| Cancer | activates | disease | 0.95 |
| P53 | associated_with | protein | 0.95 |
| TP53 | inhibits | gene | 0.92 |
| p53 | regulates | entity | 0.90 |
| p53 | inhibits | protein | 0.90 |
| p53 | interacts_with | protein | 0.90 |
| TP53 | interacts_with | gene | 0.90 |
| cancer | associated_with | disease | 0.90 |
| carcinogenesis | promotes | process | 0.85 |
| Inflammation | activates | disease | 0.85 |
| Tumor | inhibits | disease | 0.85 |
| Tumor | activates | disease | 0.85 |
| Als | inhibits | disease | 0.85 |
| Aging | therapeutic_target | disease | 0.85 |
| Als | therapeutic_target | disease | 0.85 |
| CANCER | activates | gene | 0.80 |
| P53 | inhibits | gene | 0.80 |
| MITOCHONDRIA | activates | gene | 0.80 |
| DNA | activates | gene | 0.80 |
| GENES | activates | gene | 0.80 |
| Als | regulates | disease | 0.75 |
| Neurodegeneration | activates | disease | 0.75 |
| Cancer | inhibits | disease | 0.75 |
| Fibrosis | therapeutic_target | disease | 0.75 |
| Parkinson | activates | disease | 0.75 |
| Cancer | regulates | disease | 0.75 |
| Senescence | regulates | disease | 0.75 |
| Tumor | regulates | disease | 0.75 |
| immunity | regulates | process | 0.75 |
| GENES | inhibits | gene | 0.70 |
| Apoptosis | inhibits | pathway | 0.70 |
| Apoptosis | therapeutic_target | pathway | 0.70 |
| Mapk | therapeutic_target | pathway | 0.70 |
| Ferroptosis | activates | pathway | 0.70 |
| Cell Cycle | inhibits | pathway | 0.70 |
| DNA | regulates | gene | 0.70 |
| Autophagy | activates | pathway | 0.70 |
| Chaperone | therapeutic_target | pathway | 0.70 |
| Wnt | activates | pathway | 0.70 |
| P53 | interacts_with | gene | 0.70 |
| MYC | regulates | gene | 0.70 |
| Apoptosis | regulates | pathway | 0.70 |
| Ovarian Cancer | regulates | disease | 0.65 |
| Cardiac | regulates | disease | 0.65 |
| Parkinson | causes | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| P53 | activates | gene | 1.00 |
| APOPTOSIS | activates | gene | 1.00 |
| Poly(PR) | modulates | protein | 0.90 |
| Pmiγ | binds | compound | 0.90 |
| ribosomal proteins L5/L11/L23 | inhibits | protein | 0.90 |
| PMIγ | binds | drug | 0.90 |
| P53 | regulates | gene | 0.90 |
| ribosomal proteins | activates | protein | 0.80 |
| TP53 | associated_with | gene | 0.80 |
| P53 | inhibits | gene | 0.80 |
| TP53 | inhibits | gene | 0.80 |
| ribosomal protein | interacts_with | protein | 0.75 |
| ERK | activates | gene | 0.70 |
| ribosomal protein L23 | inhibits | protein | 0.70 |
| NEURODEGENERATION | activates | gene | 0.70 |
| PARKINSON | activates | gene | 0.70 |
| ribosomal protein L5 | inhibits | protein | 0.70 |
| ribosomal protein L11 | inhibits | protein | 0.70 |
| AUTOPHAGY | activates | gene | 0.70 |
| ROS | activates | gene | 0.70 |
| PTEN | activates | gene | 0.70 |
| PI3K | therapeutic_target | gene | 0.70 |
| P53 | therapeutic_target | gene | 0.70 |
| PARKINSON'S DISEASE | activates | gene | 0.70 |
| TP53 | therapeutic_target | gene | 0.70 |
| FERROPTOSIS | activates | gene | 0.70 |
| BAX | activates | gene | 0.70 |
| BCL2A1 | activates | gene | 0.60 |
| CASP3 | activates | gene | 0.60 |
| CASP6 | activates | gene | 0.60 |
| CEBPB | activates | gene | 0.60 |
| MCL1 | activates | gene | 0.60 |
| CDK4 | causes | gene | 0.60 |
| GENES | regulates | gene | 0.60 |
| DNA | regulates | gene | 0.60 |
| AGING | expressed_in | gene | 0.60 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 0.60 |
| FERROPTOSIS | therapeutic_target | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| WNT | activates | gene | 0.60 |
| KRAS | regulates | gene | 0.60 |
| MOTOR NEURONS | causes | gene | 0.60 |
| BCL2 FAMILY | causes | gene | 0.60 |
| P53 | associated_with | gene | 0.60 |
| BRCA1 | regulates | gene | 0.60 |
| UBIQUITIN | activates | gene | 0.60 |
| NR4A1 | activates | gene | 0.60 |
| GAIN | therapeutic_target | gene | 0.60 |
| PUMA | activates | gene | 0.60 |
| BID | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.661
neurodegeneration | 2026-04-04 | 16 hypotheses Top: 0.779
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.46 · 2026-04-27
closed · Rounds: 4 · Score: 0.46 · 2026-04-27
closed · Rounds: 4 · Score: 0.61 · 2026-04-16
closed · Rounds: 4 · Score: 0.95 · 2026-04-10
Hypotheses and analyses mentioning MDM2 in their description or question text
No additional research found